Medistim ASA
Research Medistim ASA (0OCD) on Bullrun: P/E 45.5. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker0OCD
- ExchangeLSE
- CountryNorway
- SectorHealthcare
- IndustryMedical Devices
- CurrencyNOK
- P/E45.5
- Financial periodQ4 2025
- RevenueNOK 182.30M
- Net incomeNOK 38.09M
- Free cash flowNOK 66.01M
- Gross margin80.2%
Valuation Snapshot
P/E is 45.5.
Peer valuation comparison
Latest P/E is 45.47x versus a Healthcare sector median of 23.83x (90.8% above).
Latest P/E is 45.47x versus a Norway median of 16.87x (169.5% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-11 | n/a | 45.5 | n/a | 8 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 8 NOK.
About Medistim ASA
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Medistim ASA's P/E ratio?
Medistim ASA's price-to-earnings (P/E) ratio is 45.5.
What does Medistim ASA do?
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally.